DE3361453D1 - 9-dihydro-11,12-ketal derivatives of erythromycin a and epi-erythromycin a - Google Patents

9-dihydro-11,12-ketal derivatives of erythromycin a and epi-erythromycin a

Info

Publication number
DE3361453D1
DE3361453D1 DE8383300937T DE3361453T DE3361453D1 DE 3361453 D1 DE3361453 D1 DE 3361453D1 DE 8383300937 T DE8383300937 T DE 8383300937T DE 3361453 T DE3361453 T DE 3361453T DE 3361453 D1 DE3361453 D1 DE 3361453D1
Authority
DE
Germany
Prior art keywords
erythromycin
epi
dihydro
ketal derivatives
ketal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8383300937T
Other languages
German (de)
English (en)
Inventor
Frank C Sciavolino
James R Hauske
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp Belgium
Pfizer Corp SRL
Original Assignee
Pfizer Corp Belgium
Pfizer Corp SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp Belgium, Pfizer Corp SRL filed Critical Pfizer Corp Belgium
Application granted granted Critical
Publication of DE3361453D1 publication Critical patent/DE3361453D1/de
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DE8383300937T 1982-03-01 1983-02-23 9-dihydro-11,12-ketal derivatives of erythromycin a and epi-erythromycin a Expired DE3361453D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/353,548 US4382086A (en) 1982-03-01 1982-03-01 9-Dihydro-11,12-ketal derivatives of erythromycin A and epi-erythromycin A

Publications (1)

Publication Number Publication Date
DE3361453D1 true DE3361453D1 (en) 1986-01-23

Family

ID=23389607

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8383300937T Expired DE3361453D1 (en) 1982-03-01 1983-02-23 9-dihydro-11,12-ketal derivatives of erythromycin a and epi-erythromycin a

Country Status (8)

Country Link
US (1) US4382086A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0087916B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS58159500A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3361453D1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK159853C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR77921B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE54431B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
YU (1) YU42841B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8421429D0 (en) * 1984-08-23 1984-09-26 Beecham Group Plc Chemical compounds
EP0184921A3 (en) * 1984-12-08 1986-10-29 Beecham Group Plc Erythromycin derivatives
DK109886A (da) 1985-03-12 1986-09-13 Beecham Group Plc Erythromycinderivater
US4640910A (en) * 1985-11-12 1987-02-03 Abbott Laboratories Erythromycin A silylated compounds and method of use
US4681872A (en) * 1985-11-12 1987-07-21 Abbott Laboratories Erythromycin A 11,12-carbonate and method of use
WO1992006991A1 (fr) * 1990-10-15 1992-04-30 Taisho Pharmaceutical Co., Ltd. Erythromycine modifiee en 2' ou derive de cette substance
US20040005641A1 (en) * 2002-02-15 2004-01-08 Michael Burnet Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
HRP20040850A2 (en) * 2002-02-15 2005-08-31 Synovo Gmbh Conjugates of biologically active compounds, methods for their preparation and use formulation and pharmaceutical applications thereof
US7271154B2 (en) * 2002-02-15 2007-09-18 Merckle Gmbh Antibiotic conjugates
DE60325377D1 (de) * 2002-08-29 2009-01-29 Pfizer Motilidverbindungen
US7211568B2 (en) * 2003-12-18 2007-05-01 Kosan Biosciences Incorporated 9-Desoxoerythromycin compounds as prokinetic agents
JP2009502838A (ja) * 2005-07-26 2009-01-29 メルクレ,ゲーエムベーハー ピロリジンおよびインドリジン化合物のマクロライド接合体

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2653899A (en) * 1952-04-14 1953-09-29 Lilly Co Eli Erythromycin, its salts, and method of preparation
US3417077A (en) * 1966-05-16 1968-12-17 Lilly Co Eli Erythromycin derivative and process for the preparation thereof
US3884904A (en) * 1973-06-21 1975-05-20 Abbott Lab 11-Substituted erythromycin B derivatives
US3884903A (en) * 1973-06-21 1975-05-20 Abbott Lab 4{41 -Deoxy-4{41 -oxoerythromycin B derivatives
US4150220A (en) * 1977-02-04 1979-04-17 Pfizer Inc. Semi-synthetic 4"-erythromycin A derivatives

Also Published As

Publication number Publication date
JPH0142275B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1989-09-11
EP0087916A1 (en) 1983-09-07
US4382086A (en) 1983-05-03
YU42841B (en) 1988-12-31
IE54431B1 (en) 1989-10-11
DK96983A (da) 1983-09-02
DK159853B (da) 1990-12-17
YU45983A (en) 1986-02-28
EP0087916B1 (en) 1985-12-11
DK159853C (da) 1991-05-13
DK96983D0 (da) 1983-02-28
JPS58159500A (ja) 1983-09-21
GR77921B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1984-09-25
IE830410L (en) 1983-09-01

Similar Documents

Publication Publication Date Title
JPS57158798A (en) Novel erythromycin a derivative, manufacture and use
ZA866443B (en) Erythromycin derivatives
GB8410727D0 (en) Azet-2-one derivatives
GB8300400D0 (en) 5-methylthiopyrimidine derivatives
GB2128188B (en) Propynylaminoisoxazole derivatives
EP0096296A3 (en) 1-sulfo-2-oxoazetidine derivatives
HK30486A (en) Halogenbiphenyl derivatives
DE3263164D1 (en) Erythromycin b derivatives
ZA841592B (en) Macrolide derivatives
DE3377576D1 (en) C-20-modified macrolide derivatives
DE3361453D1 (en) 9-dihydro-11,12-ketal derivatives of erythromycin a and epi-erythromycin a
GB2135670B (en) C-20- and c-23-modified macrolide derivatives
EP0100250A3 (en) Methylflavone derivatives
GB2132617B (en) Propynlaminothiazole derivatives
DE3263301D1 (en) Erythromycin a derivatives
GB8330016D0 (en) 2-piperazinyl-quinazoline derivatives
GB2123815B (en) Aletheine derivatives
GB2124215B (en) Eburnane-oxime derivatives
GB2131803B (en) Oxacephalosporin derivatives
PH16669A (en) Erythromycylamine 11,12-carbonate and derivatives thereof
DE3468883D1 (en) Macrolide derivatives
ZA841277B (en) C-20-and c-23-modified macrolide derivatives
GB2121786B (en) 23-demycinosyldesmycosin derivatives
GB2116170B (en) 23-0-acyl-23-demycinosyldesmycosin derivatives
GB8326187D0 (en) 15-cycloaliphatic derivatives

Legal Events

Date Code Title Description
8364 No opposition during term of opposition